Kexing Biopharm Co., Ltd. Class A news

Investor announcements, newest first.

Close
Company news
Kexing Biopharm Co., Ltd. Class A
Mar 31, 2026
Mar 31
Mar 31, 2026
Original

Announcement on Voluntary Disclosure of GB19 Injection Obtaining FDA Clinical Trial Approval for New Drugs

Announcement on Voluntary Disclosure of GB19 Injection Obtaining FDA Clinical Trial Approval for New Drugs

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment